about
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs diseaseDevelopment of a New Tool for 3D Modeling for Regenerative MedicineCombined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy.Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophyLentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy.RNA interference as a tool for Alzheimer's disease therapy.MicroRNA implications across neurodevelopment and neuropathology.MicroRNAs and Molecular Mechanisms of Neurodegeneration.Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients.Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts.Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy.Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells.Protein encapsulation in biodegradable polymeric nanoparticles: morphology, fluorescence behaviour and stem cell uptake.Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models.Nitric oxide depletion alters hematopoietic stem cell commitment toward immunogenic dendritic cells.Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs).Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model.Critical issues for the proper diagnosis of Metachromatic Leukodystrophy.Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy.In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.Analysis of galactocerebrosidase activity in the mouse brain by a new histological staining method.The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development.Specific determination of beta-galactocerebrosidase activity via competitive inhibition of beta-galactosidase.Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology.Hydrogenated amorphous carbon nanopatterned film designs drive human bone marrow mesenchymal stem cell cytoskeleton architecture.Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia.Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus.A new analytical bench assay for the determination of arylsulfatase a activity toward galactosyl-3-sulfate ceramide: implication for metachromatic leukodystrophy diagnosis.PVA bio-nanocomposites: a new take-off using cellulose nanocrystals and PLGA nanoparticles.Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNSPlatelet glycohydrolase activities: Characterization and releaseBiocompatible Poly(L-lactide)/MWCNT Nanocomposites: Morphological Characterization, Electrical Properties, and Stem Cell InteractionDistribution of active α- and β-subunits of β-N-acetylhexosaminidase as a function of leukaemic cell typesβ N-acetylhexosaminidases A and S have similar sub-cellular distributions in HL-60 cellsKnock-down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC-derived dendritic cells
P50
Q29395388-083EA148-93F6-4D6C-89E9-9D53C02641A0Q30502339-FB648703-E6CC-413F-906C-6ABB5E1436FCQ30657387-13883F9F-99A9-49BD-9068-0F7A3DABF61EQ33649318-E067F028-7F40-41AA-807B-0D2C609F8118Q34356914-31C6847C-17B0-4A8E-9996-F926329BABBFQ35590505-75BD1304-5688-495F-A0B4-0EFD1D58B70BQ37018081-BD476453-089C-4E2B-AFE9-20563509DF66Q37617954-2BDBA66F-01E0-4E1C-8428-378EFB47AD38Q38202497-B4FD5DD0-4B97-4BBC-909C-E050C0CF3C7FQ40043003-D5258DAD-392E-4CC0-BF0A-C1D68F804B3AQ40162750-04E92304-0DC7-407A-98D5-4DBF9E793347Q42817051-9FE6584B-1843-4BAE-AA19-3E1BF6A3F0A7Q43120358-E04DD42D-B79D-472F-AA1F-69CECB867254Q44111017-923923FE-E822-4900-9F27-BD512993A6D6Q44248662-917309A6-D853-4567-80D0-4AA956F60831Q44304329-5FAE313B-5ED8-4021-B125-41743E44F6BBQ44550327-4FBAAFD3-E087-4943-A2A5-A5DFC0993102Q44672038-B15DC33C-CF70-4F9C-9DAC-E2465BC1AF05Q44858665-B6EAD6A8-F37B-4F96-B8C2-11161B8210FCQ44955393-D8F55D07-1B79-4DC6-9BBA-249795800152Q45865095-5E90156C-9FA9-4910-A043-3A42C9E202A2Q45875261-D9B39B17-007E-4728-B61D-4D1E6EEB3A2DQ45876595-AEBD2108-7A40-4307-B94E-A8E4576D16B0Q45880998-82952561-4F60-490B-9F52-A14F1C8E2DB7Q46160724-84D1C87B-BDE5-429C-A68E-627203AF84BEQ48790769-A6FDF826-C9D7-463C-BAFB-4068A553D7A3Q51736826-C450C9CF-8D6B-402A-A538-26150606D8E4Q53279468-2B88CFC2-E5E6-4FF4-93F1-9E2A284C3FCDQ53316784-13CFFAE8-FDB3-43B4-B838-DB5A44931B9DQ54505719-C8D831F6-A592-46F1-86B6-2496DC4DCF36Q54538438-819AED74-CCE6-4203-8D85-50C05DEE75D9Q57675694-4501BCEC-F5A3-4A46-B712-4DEF8E2C8989Q57675744-B40825CA-BACF-48D8-B53A-34DAB74A2BCBQ60166002-C747E17E-1F66-4502-B710-6ADF77BBCFC7Q61068632-89143C94-FA19-41CA-A94B-4B665DFB7F8DQ61068634-022A36A4-F647-44A0-BE35-D9F75BE06C11Q63208903-C0BBE8C7-6FF8-402F-A1FC-7F68745F4236
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sabata Martino
@ast
Sabata Martino
@en
Sabata Martino
@es
Sabata Martino
@nl
Sabata Martino
@sl
type
label
Sabata Martino
@ast
Sabata Martino
@en
Sabata Martino
@es
Sabata Martino
@nl
Sabata Martino
@sl
prefLabel
Sabata Martino
@ast
Sabata Martino
@en
Sabata Martino
@es
Sabata Martino
@nl
Sabata Martino
@sl
P1053
F-2309-2014
P106
P31
P3829
P496
0000-0002-3942-237X